文献速递类风湿关节炎脊柱关节炎

心外膜脂肪作为炎症性关节炎的心血管危险因素

Epicardial fat as a cardiovascular risk factor in inflammatory arthritis.
PubMed 文献 · Semin Arthritis Rheum · 2026-04-19

校正年龄、性别和Framingham风险评分后,SpA患者EFV显著高于RA,且高敏C反应蛋白和冠脉钙化评分与EFV升高相关,而临床疾病活动指数无此关联。

要点

  • SpA患者心外膜脂肪体积显著高于RA患者。
  • 高敏C反应蛋白与心外膜脂肪体积升高相关。
  • 冠脉钙化评分是唯一与EFV升高相关的外周动脉粥样硬化标志物。

核心结论

  • SpA患者心外膜脂肪体积较高,且与炎症标志物和冠状动脉粥样硬化相关,提示该人群心血管风险增加。

主要发现

  • 校正年龄和性别后,SpA患者EFV显著高于RA(104.2 ± 46.7 vs. 86.7 ± 47.9 ml,p = 0.004;β 18.3,95%CI 5.5-31.1)。
  • 校正Framingham风险评分后,SpA患者EFV仍显著高于RA(β 17.4,95%CI 5.8-28.9)。
  • 高敏C反应蛋白与EFV升高相关(校正FRS后β 0.97,95%CI 0.39-1.56)。
  • 各关节炎临床疾病活动指数与EFV无类似关联。
  • 在动脉粥样硬化标志物中,仅冠脉钙化评分与EFV升高相关(校正FRS后β 0.02,95%CI 0.01-0.05)。

关键数值与推荐

  • SpA患者EFV为104.2 ± 46.7 ml,RA患者为86.7 ± 47.9 ml,组间比较p = 0.004。
  • 校正年龄和性别后β = 18.3(95%CI 5.5-31.1),校正FRS后β = 17.4(95%CI 5.8-28.9)。
  • 高敏C反应蛋白与EFV的校正FRS后β = 0.97(95%CI 0.39-1.56)。
  • 冠脉钙化评分与EFV的校正FRS后β = 0.02(95%CI 0.01-0.05)。

临床怎么用

  • 对SpA患者应关注心外膜脂肪体积及冠状动脉钙化等心血管风险标志物。
  • 炎症标志物高敏C反应蛋白升高可能提示心外膜脂肪增加及心血管风险。
  • 临床疾病活动指数不能替代影像学或炎症标志物评估心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cardiovascular disease (CVD) is the leading cause of death in inflammatory arthritis. Epicardial fat has emerged as a novel marker of CVD. Therefore, we examined the association of epicardial fat volume (EFV) with disease activity and other atherosclerotic CV markers in patients with inflammatory arthritis. METHODS: Patients with rheumatoid arthritis (RA) (n = 114) and spondyloarthritis (SpA), including ankylosing spondylitis (n = 28) and psoriatic arthritis (n = 100) were recruited. EFV was assessed from coronary artery calcium scoring (CACS) computed tomography scans. Additionally, carotid atherosclerotic markers were obtained by carotid ultrasound. We compared EFV between RA and SpA patients and assessed the association between EFV and disease activity indices, inflammatory and atherosclerotic markers using regression models adjusted for age, sex and the Framingham risk score (FRS). RESULTS: EFV was significantly higher in SpA versus RA after adjusting for age and sex ((104.2 ± 46.7 vs. 86.7 ± 47.9 ml, p = 0.004; β 18.3, 95% confidence interval (CI) 5.5-31.1) or after adjusting for FRS (β 17.4, 95% CI 5.8-28.9). While high sensitivity C-reactive protein was associated with elevated EFV (β adjusted for FRS 0.97, 95% CI 0.39-1.56), no similar association was found between individual arthritis-clinical disease activity indices and EFV. Among atherosclerotic markers, only CACS was associated with elevated EFV (β adjusted for FRS 0.02, 95% CI 0.01-0.05). CONCLUSION: Higher EFV in SpA and its association with inflammatory markers and coronary atherosclerosis highlight the increased CV risk in this population.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Das S, Wu W, Harvey P, et al. Epicardial fat as a cardiovascular risk factor in inflammatory arthritis. Semin Arthritis Rheum. 2026. PMID: 42048996. doi:10.1016/j.semarthrit.2026.152985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。